Alexandria Real Estate Equities, Inc. $ARE Shares Purchased by Hahn Capital Management LLC

Hahn Capital Management LLC grew its stake in Alexandria Real Estate Equities, Inc. (NYSE:ARE) by 45.9% in the third quarter, HoldingsChannel.com reports. The fund owned 84,823 shares of the real estate investment trust’s stock after acquiring an additional 26,705 shares during the period. Alexandria Real Estate Equities makes up 2.4% of Hahn Capital Management LLC’s investment portfolio, making the stock its 22nd largest position. Hahn Capital Management LLC’s holdings in Alexandria Real Estate Equities were worth $4,026,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. BlackRock Inc. bought a new stake in Alexandria Real Estate Equities in the second quarter valued at approximately $1,146,423,000. Dimensional Fund Advisors LP boosted its position in shares of Alexandria Real Estate Equities by 2.3% during the first quarter. Dimensional Fund Advisors LP now owns 2,297,222 shares of the real estate investment trust’s stock worth $106,638,000 after purchasing an additional 52,733 shares in the last quarter. Bank of New York Mellon Corp bought a new position in shares of Alexandria Real Estate Equities during the second quarter worth $79,253,000. Legal & General Group Plc bought a new position in shares of Alexandria Real Estate Equities during the second quarter worth $76,647,000. Finally, Hsbc Holdings PLC acquired a new position in shares of Alexandria Real Estate Equities in the 2nd quarter valued at $64,485,000. 96.54% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, CAO Andres Gavinet sold 10,000 shares of Alexandria Real Estate Equities stock in a transaction that occurred on Monday, August 31st. The shares were sold at an average price of $50.93, for a total value of $509,300.00. Following the sale, the chief accounting officer directly owned 102,516 shares in the company, valued at $5,221,139.88. This trade represents a 8.89% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Kristina Fukuzaki-Carlson sold 16,810 shares of Alexandria Real Estate Equities stock in a transaction that occurred on Friday, September 11th. The shares were sold at an average price of $50.51, for a total transaction of $849,073.10. Following the completion of the sale, the executive vice president owned 39,152 shares in the company, valued at $1,977,567.52. This trade represents a 30.04% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 1.35% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on ARE shares. JPMorgan Chase & Co. cut Alexandria Real Estate Equities from a “neutral” rating to an “underweight” rating and set a $56.00 target price for the company. in a research note on Thursday, September 24th. The Goldman Sachs Group raised their price target on Alexandria Real Estate Equities from $54.00 to $59.00 and gave the stock a “neutral” rating in a research report on Friday, September 18th. Jefferies Financial Group dropped their price target on Alexandria Real Estate Equities from $47.00 to $46.00 and set a “hold” rating on the stock in a research report on Thursday, September 24th. BNP Paribas Exane cut their price objective on Alexandria Real Estate Equities from $40.00 to $37.00 and set an “underperform” rating on the stock in a report on Wednesday, October 28th. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of Alexandria Real Estate Equities in a research report on Thursday, October 15th. Two analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and four have issued a Sell rating to the stock. According to data from MarketBeat.com, Alexandria Real Estate Equities currently has a consensus rating of “Reduce” and a consensus target price of $49.79.

Alexandria Real Estate Equities Stock Performance

Shares of Alexandria Real Estate Equities stock opened at $45.90 on Thursday. The firm has a market cap of $7.99 billion, a price-to-earnings ratio of -5.45 and a beta of 1.17. The stock’s 50-day moving average is $47.51 and its 200-day moving average is $49.51. Alexandria Real Estate Equities, Inc. has a one year low of $38.34 and a one year high of $59.76. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.14 and a quick ratio of 0.14.

Alexandria Real Estate Equities (NYSE:ARE) last posted its quarterly earnings data on Monday, October 26th. The real estate investment trust reported ($3.74) earnings per share for the quarter, missing the consensus estimate of ($0.03) by ($3.71). The firm had revenue of $671.18 million for the quarter, compared to analyst estimates of $646.26 million. Alexandria Real Estate Equities had a negative return on equity of 7.52% and a negative net margin of 51.81%. The firm’s quarterly revenue was down 10.7% on a year-over-year basis. During the same period in the prior year, the company earned $2.22 earnings per share. Equities analysts predict that Alexandria Real Estate Equities, Inc. will post 6.39 earnings per share for the current fiscal year.

Alexandria Real Estate Equities Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, October 15th. Shareholders of record on Wednesday, September 30th were paid a $0.72 dividend. The ex-dividend date was Wednesday, September 30th. This represents a $2.88 annualized dividend and a yield of 6.3%. Alexandria Real Estate Equities’s payout ratio is presently -34.20%.

Alexandria Real Estate Equities Company Profile

Alexandria Real Estate Equities, Inc (NYSE:ARE) is a real estate investment trust that owns, operates and develops collaborative life science, agtech and advanced technology campuses. Its properties are designed for companies, research institutions and government agencies engaged in biotechnology, pharmaceuticals, medical devices, agriculture technology and related fields.

The company provides laboratory, office and research space, along with supporting amenities and infrastructure intended to foster collaboration among its tenants.